WHO Tackles Submission Of Insufficient Or False Data By Pharma
This article was originally published in SRA
Executive Summary
The World Health Organization has developed what it claims is the first comprehensive guidance document on data integrity that should help regulatory authorities and inspectors identify instances of pharmaceutical companies submitting insufficient or false data1.